BACKGROUND: Coenzyme Q10 (CoQ10) is a component of the mitochondrial electron transport chain and is considered an important cellular antioxidant. Decreased circulating CoQ10 levels have been reported in women with breast cancer, but evidence is limited. We examined the association of plasma CoQ10 levels with postmenopausal breast cancer risk using prospectively collected blood samples. METHODS: Prediagnostic plasma levels of total CoQ10 were measured among 160 incident postmenopausal breast cancer cases and 289 controls in the Multiethnic Cohort Study. Cases and controls were individually matched on age, sex, ethnicity, study location (Hawaii or California), hormone replacement therapy use, date and time of specimen collection, and hours of fasting. Logistic regression was used to compute odds ratios and 95% confidence intervals. RESULTS: Plasma CoQ10 levels were positively associated with breast cancer risk, overall (P = 0.04). The association was stronger after women diagnosed within 1 year of blood draw were excluded to eliminate possible preclinical cases (odds ratio for the highest versus the lowest tertile, 2.26; 95% confidence interval, 1.22-4.19; P for trend = 0.01). CONCLUSIONS: Higher CoQ10 levels in postmenopausal women may be associated with increased breast cancer risk. IMPACT: A potential role for CoQ10 in the development and progression of breast cancer has been postulated, but epidemiologic evidence is lacking. Findings from this prospective cohort study add to the limited literature, indicating the potential positive association of circulating CoQ10 with postmenopausal breast cancer risk. (c)2010 AACR.
BACKGROUND: Coenzyme Q10 (CoQ10) is a component of the mitochondrial electron transport chain and is considered an important cellular antioxidant. Decreased circulating CoQ10 levels have been reported in women with breast cancer, but evidence is limited. We examined the association of plasma CoQ10 levels with postmenopausal breast cancer risk using prospectively collected blood samples. METHODS: Prediagnostic plasma levels of total CoQ10 were measured among 160 incident postmenopausal breast cancer cases and 289 controls in the Multiethnic Cohort Study. Cases and controls were individually matched on age, sex, ethnicity, study location (Hawaii or California), hormone replacement therapy use, date and time of specimen collection, and hours of fasting. Logistic regression was used to compute odds ratios and 95% confidence intervals. RESULTS: Plasma CoQ10 levels were positively associated with breast cancer risk, overall (P = 0.04). The association was stronger after women diagnosed within 1 year of blood draw were excluded to eliminate possible preclinical cases (odds ratio for the highest versus the lowest tertile, 2.26; 95% confidence interval, 1.22-4.19; P for trend = 0.01). CONCLUSIONS: Higher CoQ10 levels in postmenopausal women may be associated with increased breast cancer risk. IMPACT: A potential role for CoQ10 in the development and progression of breast cancer has been postulated, but epidemiologic evidence is lacking. Findings from this prospective cohort study add to the limited literature, indicating the potential positive association of circulating CoQ10 with postmenopausal breast cancer risk. (c)2010 AACR.
Authors: Prabhudas R Palan; Kathleen Connell; Elizabeth Ramirez; Christian Inegbenijie; Rachana Y Gavara; Jacob A Ouseph; Magdy S Mikhail Journal: Biofactors Date: 2005 Impact factor: 6.113
Authors: P Jolliet; N Simon; J Barré; J Y Pons; M Boukef; B J Paniel; J P Tillement Journal: Int J Clin Pharmacol Ther Date: 1998-09 Impact factor: 1.366
Authors: Motoki Iwasaki; Adrian A Franke; Gerson S Hamada; Nelson T Miyajima; Sangita Sharma; Junko Ishihara; Ribeka Takachi; Shoichiro Tsugane; Loïc Le Marchand Journal: Eur J Cancer Prev Date: 2015-03 Impact factor: 2.497
Authors: Weiwen Chai; Rachel Novotny; Gertraud Maskarinec; Loic Le Marchand; Adrian A Franke; Robert V Cooney Journal: J Am Coll Nutr Date: 2014-05-08 Impact factor: 3.169
Authors: Chris Shidal; Hyung-Suk Yoon; Wei Zheng; Jie Wu; Adrian A Franke; William J Blot; Xiao-Ou Shu; Qiuyin Cai Journal: Cancer Med Date: 2021-02-06 Impact factor: 4.452
Authors: Eman El-Attar; Amel Kamel; Ahmed Karmouty; Nadine Wehida; Rasha Nassra; Mohamed El Nemr; Noha Said Kandil Journal: Asian Pac J Cancer Prev Date: 2020-02-01